OtherCommentary
PDA Points to Consider: Technical Product Lifecycle Management Pharmaceutical Quality System Effectiveness For Managing Post-Approval Changes
Emma Ramnarine, Ursula Busse, Franck Chassant, Marcello Colao, Julia Edwards, Kevin O'Donnell, Maik Jornitz, Morten Munk, Melissa Seymour, Mihaela Simianu, Lisa Skeens and Anders Vinther
PDA Journal of Pharmaceutical Science and Technology February 2017, pdajpst.2017.007575; DOI: https://doi.org/10.5731/pdajpst.2017.007575
Emma Ramnarine
1 Genentech;
Ursula Busse
2 Novartis;
Franck Chassant
3 Sanofi Pasteur;
Marcello Colao
4 Glaxo Smith Kline;
Julia Edwards
5 Biogen;
Kevin O'Donnell
6 HPRA;
Maik Jornitz
7 G-Con;
Morten Munk
8 NNE Pharmaplan;
Melissa Seymour
5 Biogen;
Mihaela Simianu
9 Pharmatech Associates;
Lisa Skeens
10 Pfizer;
Anders Vinther
11 Sanofi-Pasteur
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 78, Issue 4
July/August 2024
PDA Points to Consider: Technical Product Lifecycle Management Pharmaceutical Quality System Effectiveness For Managing Post-Approval Changes
Emma Ramnarine, Ursula Busse, Franck Chassant, Marcello Colao, Julia Edwards, Kevin O'Donnell, Maik Jornitz, Morten Munk, Melissa Seymour, Mihaela Simianu, Lisa Skeens, Anders Vinther
PDA Journal of Pharmaceutical Science and Technology Feb 2017, pdajpst.2017.007575; DOI: 10.5731/pdajpst.2017.007575
PDA Points to Consider: Technical Product Lifecycle Management Pharmaceutical Quality System Effectiveness For Managing Post-Approval Changes
Emma Ramnarine, Ursula Busse, Franck Chassant, Marcello Colao, Julia Edwards, Kevin O'Donnell, Maik Jornitz, Morten Munk, Melissa Seymour, Mihaela Simianu, Lisa Skeens, Anders Vinther
PDA Journal of Pharmaceutical Science and Technology Feb 2017, pdajpst.2017.007575; DOI: 10.5731/pdajpst.2017.007575
Jump to section
Related Articles
- No related articles found.